A detailed history of Canada Pension Plan Investment Board transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 2,699,863 shares of GILD stock, worth $226 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,699,863
Previous 1,410,443 91.42%
Holding current value
$226 Million
Previous $103 Million 79.3%
% of portfolio
0.19%
Previous 0.11%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$63.15 - $72.88 $81.4 Million - $94 Million
1,289,420 Added 91.42%
2,699,863 $185 Million
Q1 2024

May 14, 2024

BUY
$71.58 - $87.29 $5.77 Million - $7.04 Million
80,666 Added 6.07%
1,410,443 $103 Million
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $16.4 Million - $18.6 Million
-223,700 Reduced 14.4%
1,329,777 $108 Million
Q3 2023

Nov 09, 2023

BUY
$73.94 - $80.67 $11.6 Million - $12.6 Million
156,300 Added 11.19%
1,553,477 $116 Million
Q2 2023

Aug 09, 2023

SELL
$76.01 - $86.7 $2.3 Million - $2.63 Million
-30,300 Reduced 2.12%
1,397,177 $108 Million
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $11.8 Million - $13.4 Million
152,248 Added 11.94%
1,427,477 $118 Million
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $4.33 Million - $6.21 Million
-69,420 Reduced 5.16%
1,275,229 $109 Million
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $29.1 Million - $33.2 Million
-488,100 Reduced 26.63%
1,344,649 $83 Million
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $28.1 Million - $31.6 Million
486,400 Added 36.13%
1,832,749 $113 Million
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $22.9 Million - $28.7 Million
-395,974 Reduced 22.73%
1,346,349 $80 Million
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $28.1 Million - $31.9 Million
-433,035 Reduced 19.91%
1,742,323 $127 Million
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $16.1 Million - $17.3 Million
-237,356 Reduced 9.84%
2,175,358 $152 Million
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $8.65 Million - $9.45 Million
136,218 Added 5.98%
2,412,714 $166 Million
Q1 2021

May 17, 2021

BUY
$60.0 - $68.46 $48.1 Million - $54.9 Million
801,323 Added 54.32%
2,276,496 $147 Million
Q4 2020

Feb 17, 2021

BUY
$56.65 - $64.55 $18.8 Million - $21.5 Million
332,336 Added 29.08%
1,475,173 $85.9 Million
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $11.6 Million - $14.6 Million
187,429 Added 19.62%
1,142,837 $72.2 Million
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $29.9 Million - $34.7 Million
-412,822 Reduced 30.17%
955,408 $73.5 Million
Q1 2020

May 13, 2020

SELL
$62.63 - $80.22 $38.7 Million - $49.6 Million
-618,126 Reduced 31.12%
1,368,230 $102 Million
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $32 Million - $35.2 Million
-519,282 Reduced 20.72%
1,986,356 $129 Million
Q3 2019

Nov 12, 2019

SELL
$62.51 - $69.0 $15.9 Million - $17.6 Million
-255,071 Reduced 9.24%
2,505,638 $159 Million
Q2 2019

Aug 12, 2019

SELL
$61.87 - $69.38 $11.6 Million - $13 Million
-187,233 Reduced 6.35%
2,760,709 $187 Million
Q1 2019

May 15, 2019

BUY
$62.53 - $70.05 $71.1 Million - $79.7 Million
1,137,644 Added 62.84%
2,947,942 $192 Million
Q4 2018

Feb 06, 2019

SELL
$60.54 - $79.0 $41.7 Million - $54.5 Million
-689,400 Reduced 27.58%
1,810,298 $113 Million
Q3 2018

Nov 09, 2018

SELL
$71.28 - $78.92 $11.9 Million - $13.1 Million
-166,396 Reduced 6.24%
2,499,698 $193 Million
Q2 2018

Aug 07, 2018

SELL
$64.88 - $75.68 $30.2 Million - $35.2 Million
-465,125 Reduced 14.85%
2,666,094 $189 Million
Q1 2018

May 14, 2018

SELL
$72.84 - $88.8 $25.4 Million - $30.9 Million
-348,375 Reduced 10.01%
3,131,219 $236 Million
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $20.9 Million - $24.5 Million
-293,800 Reduced 7.79%
3,479,594 $249 Million
Q3 2017

Oct 30, 2017

BUY
$72.11 - $85.47 $44.1 Million - $52.2 Million
611,198 Added 19.33%
3,773,394 $306 Million
Q2 2017

Jan 31, 2018

BUY
N/A
20,200 Added 0.64%
3,162,196 $224 Million
Q1 2017

Jan 31, 2018

BUY
N/A
3,141,996
3,141,996 $213 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $105B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.